199 related articles for article (PubMed ID: 28732324)
21. Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.
Minisini AM; Menis J; Valent F; Andreetta C; Alessi B; Pascoletti G; Piga A; Fasola G; Puglisi F
Anticancer Drugs; 2009 Jul; 20(6):503-7. PubMed ID: 19339872
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
[TBL] [Abstract][Full Text] [Related]
23. Prediction of postchemotherapy ovarian function using markers of ovarian reserve.
Henry NL; Xia R; Schott AF; McConnell D; Banerjee M; Hayes DF
Oncologist; 2014 Jan; 19(1):68-74. PubMed ID: 24319018
[TBL] [Abstract][Full Text] [Related]
24. Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea.
Ruddy KJ; Schaid DJ; Batzler A; Cecchini RS; Partridge AH; Norman A; Fehrenbacher L; Stewart EA; Trabuco E; Ginsburg E; Couch FJ; Fasching PA; Vachon C; Ganz PA
J Natl Cancer Inst; 2021 Aug; 113(8):1105-1108. PubMed ID: 33159444
[TBL] [Abstract][Full Text] [Related]
25. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.
Ruddy KJ; O'Neill A; Miller KD; Schneider BP; Baker E; Sparano JA; Dang C; Northfelt DW; Sledge GW; Partridge AH
Breast Cancer Res Treat; 2014 Apr; 144(3):591-7. PubMed ID: 24584876
[TBL] [Abstract][Full Text] [Related]
26. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
27. Anti-Müllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies.
Hamy AS; Porcher R; Eskenazi S; Cuvier C; Giacchetti S; Coussy F; Hocini H; Tournant B; Perret F; Bonfils S; Charvériat P; Lacorte JM; Espie M
Reprod Biomed Online; 2016 Mar; 32(3):299-307. PubMed ID: 26803206
[TBL] [Abstract][Full Text] [Related]
28. Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer. A follow-up study.
Al-Rawi SA; Saleh BO; Al-Naqqash MA
Saudi Med J; 2018 Jul; 39(7):733-735. PubMed ID: 29968900
[TBL] [Abstract][Full Text] [Related]
29. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.
Anderson RA; Mansi J; Coleman RE; Adamson DJA; Leonard RCF
Eur J Cancer; 2017 Dec; 87():58-64. PubMed ID: 29117576
[TBL] [Abstract][Full Text] [Related]
30. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients.
Bozza C; Puglisi F; Lambertini M; Osa EO; Manno M; Del Mastro L
Endocr Relat Cancer; 2014 Feb; 21(1):R51-65. PubMed ID: 24292601
[TBL] [Abstract][Full Text] [Related]
31. A quantitative comparison of anti-Müllerian hormone measurement and its shifting boundaries between two assays.
de Kat AC; Broekmans FJM; van Westing AC; Lentjes E; Verschuren WMM; van der Schouw YT
Maturitas; 2017 Jul; 101():12-16. PubMed ID: 28539163
[TBL] [Abstract][Full Text] [Related]
32. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane.
Okanami Y; Ito Y; Watanabe C; Iijima K; Iwase T; Tokudome N; Takahashi S; Hatake K
Breast Cancer; 2011 Jul; 18(3):182-8. PubMed ID: 21394515
[TBL] [Abstract][Full Text] [Related]
33. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
[TBL] [Abstract][Full Text] [Related]
34. Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women.
Dunlop CE; Anderson RA
Maturitas; 2015 Mar; 80(3):245-50. PubMed ID: 25596814
[TBL] [Abstract][Full Text] [Related]
35. The protective effect of vitamin D on ovarian reserve and anti-mullerian hormone in patients undergoing chemotherapy for breast cancer, a randomized phase ΙΙ clinical trial.
Dastmardi Z; Lashkari M; Saeedian A; Aghili M; Alipour S
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2104. PubMed ID: 38925607
[TBL] [Abstract][Full Text] [Related]
36. Five-year study assessing the clinical utility of anti-Müllerian hormone measurements in reproductive-age women with cancer.
Palinska-Rudzka KE; Ghobara T; Parsons N; Milner J; Lockwood G; Hartshorne GM
Reprod Biomed Online; 2019 Oct; 39(4):712-720. PubMed ID: 31471141
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
[TBL] [Abstract][Full Text] [Related]
38. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.
Ben-Aharon I; Meizner I; Granot T; Uri S; Hasky N; Rizel S; Yerushalmi R; Sulkes A; Stemmer SM
Oncologist; 2012; 17(11):1386-93. PubMed ID: 22956534
[TBL] [Abstract][Full Text] [Related]
40. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
Han X; McShane M; Sahertian R; White C; Ledger W
Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
